| Literature DB >> 25461667 |
Stephane Emonet1, Timothee Wuillemin2, Stephan Harbarth3, Nasstasja Wassilew3, Mustafa Cikirikcioglu4, Jacques Schrenzel5, Jean-Christophe Lagier6, Didier Raoult6, Christian van Delden3.
Abstract
The best treatment for Tropheryma whipplei infections is controversial. We report a patient who suffered from T. whipplei aortic native valve endocarditis that relapsed despite surgery and four weeks of intravenous ceftriaxone followed by several months of oral trimethoprim/sulfamethoxazole. Cure was achieved after replacement of the prosthesis with a homograft and 18 months of oral doxycycline-hydroxychloroquine. We discuss the need for a change in treatment guidelines for T. whipplei infections.Entities:
Keywords: Doxycycline; Endocarditis; Guidelines; Hydroxychloroquine; Trimethoprim/sulfamethoxazole; Whipple's disease
Mesh:
Substances:
Year: 2014 PMID: 25461667 DOI: 10.1016/j.ijid.2014.11.003
Source DB: PubMed Journal: Int J Infect Dis ISSN: 1201-9712 Impact factor: 3.623